Search
IBIO-100
go.drugbank.com/drugs/DB18233ExperimentalIBIO-100 is a high molecular weight multimer of E3-Fc, an endostatin C-terminus and IgG1-Fc fusion protein.
VOR33
go.drugbank.com/drugs/DB18624InvestigationalVOR33 is an allogeneic CRISPR/Cas9 genome-edited hematopoietic stem and progenitor cell (HSPC) therapy product lacking the CD33 protein.
Pradofloxacin
go.drugbank.com/drugs/DB11453ExperimentalVet approvedIt was approved by the European Commission in April 2011 for bacterial infections in dogs and cats.
DCVAC/OvCa
go.drugbank.com/drugs/DB18571InvestigationalIt is under investigation for the treatment of ovarian cancer.
Inarigivir
go.drugbank.com/drugs/DB15062InvestigationalInarigivir is under investigation in clinical trial NCT03434353 (Study to Evaluate the Antiviral Activity of Inarigivir (GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis
Homeodomain-interacting protein kinase 3
go.drugbank.com/bio_entities/BE0009448TargetHumansEnhances androgen receptor-mediated transcription. May act as a transcriptional corepressor for NK homeodomain transcription factors.
Synonyms: Androgen receptor-interacting nuclear protein kinaseLixmabegagene relduparvovec
go.drugbank.com/drugs/DB16816InvestigationalIt is under development for the treatment of GM1 gangliosidosis.[L45929]
(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid
go.drugbank.com/drugs/DB03455ExperimentalThese are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is known to target interleukin-2.
Gold
go.drugbank.com/drugs/DB14154InvestigationalMany of its clinical applications, such as ANTIRHEUMATIC AGENTS, are in the form of its salts.